8-KThe WireStrategic
Agreement Terminated
Filed Mar 2, 2026 · 3mo ago · Accession 0001193125-26-085516
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Acrivon Therapeutics, Inc.
- Ticker
- ACRV
- CIK
- 1781174
- Form type
- 8-K
- Filing date
- Mar 2, 2026
- Report date
- Feb 25, 2026
- Document
- d111455d8k.htm
- Size
- 139 KB